{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:21:04Z","timestamp":1790806864401,"version":"4.1.0"},"reference-count":41,"publisher":"European Respiratory Society (ERS)","issue":"2","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["SAS117256"],"award-info":[{"award-number":["SAS117256"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Little is known about the prognosis of adults with new-onset asthma. Cross-sectional studies suggest that these patients may exhibit accelerated decline in forced expiratory volume in 1\u2005s (FEV<jats:sub>1<\/jats:sub>). However, risk factors for accelerated decline in lung function have not yet been identified.<\/jats:p><jats:p>We aimed to identify these risk factors in a prospective 5-year follow-up study in 200 adults with newly diagnosed asthma. In the current study, clinical, functional and inflammatory parameters were assessed annually for 5\u2005years. Linear mixed-effects models were used to identify predictors.<\/jats:p><jats:p>Evaluable lung function sets of 141 patients were available. Median (interquartile range) change in post-bronchodilator FEV<jats:sub>1<\/jats:sub>was \u221217.5 (\u221254.2 to +22.4) mL per year. Accelerated decline in FEV<jats:sub>1<\/jats:sub>was defined by the lower quartile of decline (&gt;54.2\u2005mL per year). Nasal polyps, number of blood and sputum eosinophils, body mass index, and level of exhaled nitric oxide were univariably associated with decline in lung function. Only the latter two were independently associated. Using cut-off values to identify patients at highest risk showed accelerated decline in FEV<jats:sub>1<\/jats:sub>in all patients with combined exhaled nitric oxide fraction (<jats:italic>F<\/jats:italic><jats:sub>eNO<\/jats:sub>) \u226557\u2005ppb and body mass index (BMI) \u226423\u2005kg\u00b7m<jats:sup>\u22122<\/jats:sup>.<\/jats:p><jats:p>We conclude that adults with new-onset asthma with both high levels of exhaled nitric oxide and low BMI are at risk of accelerated decline in lung function.<\/jats:p>","DOI":"10.1183\/13993003.01785-2017","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T01:55:21Z","timestamp":1518659721000},"page":"1701785","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":89,"title":["Predictors of accelerated decline in lung function in adult-onset asthma"],"prefix":"10.1183","volume":"51","author":[{"given":"Hanneke","family":"Coumou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus A.","family":"Westerhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma B.","family":"de Nijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko\u00a0H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth H.","family":"Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"2024101909300793000_51.2.1701785.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"2024101909300793000_51.2.1701785.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0896OC"},{"key":"2024101909300793000_51.2.1701785.3","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2678"},{"key":"2024101909300793000_51.2.1701785.4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1513\/AnnalsATS.201212-115OC","article-title":"Adult-onset asthma becomes the dominant phenotype among women by age 40 years. The longitudinal CARDIA study","volume":"10","author":"Sood","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"2024101909300793000_51.2.1701785.5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaip.2016.08.015","article-title":"Age-specific incidence of new asthma diagnoses in Finland","volume":"5","author":"Kankaanranta","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101909300793000_51.2.1701785.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.041"},{"key":"2024101909300793000_51.2.1701785.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61446-4"},{"key":"2024101909300793000_51.2.1701785.8","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.3.8087330"},{"key":"2024101909300793000_51.2.1701785.9","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113047"},{"key":"2024101909300793000_51.2.1701785.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391703"},{"key":"2024101909300793000_51.2.1701785.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00165106"},{"key":"2024101909300793000_51.2.1701785.12","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.322"},{"key":"2024101909300793000_51.2.1701785.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.07.011"},{"key":"2024101909300793000_51.2.1701785.14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.4.9807121"},{"key":"2024101909300793000_51.2.1701785.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00077803"},{"key":"2024101909300793000_51.2.1701785.16","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention 2002. Available from: http:\/\/ginasthma.org Date last accessed: September 2016."},{"key":"2024101909300793000_51.2.1701785.17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14d29.x"},{"key":"2024101909300793000_51.2.1701785.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2024101909300793000_51.2.1701785.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.9120-11ST"},{"key":"2024101909300793000_51.2.1701785.20","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1183\/09031936.02.00000302","article-title":"Sputum induction","volume":"20","author":"Paggiaro","year":"2002","journal-title":"Eur Respir J"},{"key":"2024101909300793000_51.2.1701785.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00850-2016"},{"key":"2024101909300793000_51.2.1701785.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.5.7735588"},{"key":"2024101909300793000_51.2.1701785.23","first-page":"171","article-title":"Rate of decline of lung function in subjects with asthma","volume":"70","author":"Peat","year":"1987","journal-title":"Eur J Respir Dis"},{"key":"2024101909300793000_51.2.1701785.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1126OC"},{"key":"2024101909300793000_51.2.1701785.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.01.040"},{"key":"2024101909300793000_51.2.1701785.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.4.375"},{"key":"2024101909300793000_51.2.1701785.27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00135907"},{"key":"2024101909300793000_51.2.1701785.28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"2024101909300793000_51.2.1701785.29","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.1.8542158"},{"key":"2024101909300793000_51.2.1701785.30","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1478"},{"key":"2024101909300793000_51.2.1701785.31","doi-asserted-by":"publisher","DOI":"10.1177\/0194599812442322"},{"key":"2024101909300793000_51.2.1701785.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.04.052"},{"key":"2024101909300793000_51.2.1701785.33","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.2.91"},{"key":"2024101909300793000_51.2.1701785.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02314.x"},{"key":"2024101909300793000_51.2.1701785.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.09.029"},{"key":"2024101909300793000_51.2.1701785.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.12.022"},{"key":"2024101909300793000_51.2.1701785.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201401-0178OC"},{"key":"2024101909300793000_51.2.1701785.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-231PP"},{"key":"2024101909300793000_51.2.1701785.39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaip.2017.01.027","article-title":"Cluster analysis on longitudinal data of patients with adult-onset asthma","volume":"5","author":"Ilmarinen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101909300793000_51.2.1701785.40","first-page":"CD011440","article-title":"Exhaled nitric oxide levels to guide treatment for adults with asthma","volume":"9","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101909300793000_51.2.1701785.41","first-page":"CD011439","article-title":"Exhaled nitric oxide levels to guide treatment for children with asthma","volume":"11","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01785-2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:51:28Z","timestamp":1740379888000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01785-2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,14]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1183\/13993003.01785-2017"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01785-2017","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}